Benchling

💘 Antibodies and standardized, structured data are a match made in heaven! When we were acquired by Benchling last year, it was to combine our expertise in bioinformatics with Benchling’s leading cloud platform. Together, we’re building a complete software stack for end-to-end antibody discovery and development. https://lnkd.in/dwp4RnHi Happy Valentine's Day, from our team to yours! 💗 Benchling + PipeBio = #TeamScience

We ♥️ our #Community. In less than two years, our online community has grown to become a dynamic and inspiring space for Benchling users to connect, learn, and share knowledge. We’re grateful for everyone who makes the magic happen: ✔️ 1900+ community members ✔️ 4700+ posts published ✔️ 11 local meetups, from San Diego 🌴 to London 🇬🇧 ✔️ 500+ product ideas Happy Valentine’s Day from #TeamScience! 💕 👉 Join our community: https://lnkd.in/eHD6JuZZ #BenchlingCommunity

Every February, we bring Benchling together in San Francisco to kick off a new year. The stakes felt different this year. Capital constraints are forcing biotechs to think differently. China's accelerating scientific capabilities are raising the bar on speed and cost. The industry needs a breakthrough – and I believe it will come from technology. Consider this: In 2024, the FDA approved 50 new medicines. While many are remarkable and life saving, this number has remained stagnant for a decade even as R&D costs have soared. Other complex industries faced similar scaling challenges and conquered them. In the same decade, battery costs dropped 80% catalyzing 10x growth in EV sales and computing power doubled every two years, enabling breakthroughs like self-driving cars and ChatGPT. Biotech is overdue for its own industrialization. While biology is messy and constrained by the slow and manual nature of experimentation, it is still fundamentally knowledge work. Exponential advances in AI – the cost of GPT-4 level intelligence is 1000x cheaper than 18 months ago – are a huge opportunity to accelerate scientific progress. At Benchling, we've spent a decade helping R&D teams build the foundation: centralizing and structuring their scientific data. Now, we are turning our attention to helping them leverage that foundation to generate 10x more high-quality molecules and automate critical R&D steps, dramatically reducing costs. Other technical industries are already benefitting and biotech should aim just as high. I’m looking forward to the year ahead and helping the biopharma industry build a future where not 50, but 500 new medicines are approved every year.

“Benchling has been a game-changer for how we approach in vivo R&D at Lyell.” With 3x faster data search, collation, and analysis, scientists at Lyell Immunopharma are getting time back for what really matters — developing cell therapies to defeat solid tumors. https://lnkd.in/g8QwU_-m Join us at AALAS Demo Days to discover how our latest innovations bridge the gap between in vivo scientists and the rest of the R&D organization. 📆 February 19 at 8:15am PST (4:15pm GMT) 👉 Register for free: https://lnkd.in/gbfMsiHQ

How many developers are already using #AI tools for things like writing and debugging code? According to Stack Overflow, it’s high — over 61%. But it can be difficult to get useful suggestions unless the tool understands your data model and schemas. That’s why we built our new Insights SQL assistant. This AI-powered tool already knows how your R&D data is structured, and can make intelligent recommendations to generate, modify, and debug SQL queries — all within Benchling. 👉 Get the details: https://lnkd.in/g96qYdxZ

Join us for a special Valentine's Day themed event: Benchling speed dating. 💕  That's right... you'll rotate through different groups to meet other Benchling users in the London area, so you can share ideas and learn directly from each other. 🇬🇧 Drop by to join our #Community! https://lnkd.in/eJPVY9xM

👩🏿🔬👩🏻🔬👩🏽🔬👩🏼🔬 Today is International Day of Women and Girls in Science — and we’re celebrating by giving away some of our favorite books. Whether we’re reading about revolutionary breakthroughs or the hidden biases in data, it’s clear: women are shaping the future of science, and their stories deserve to be heard. 📚 Join the celebration! One grand prize winner will receive a 1-year gift subscription to Audible, and an additional 30 lucky winners will receive one of our #BenchlingBookClub selections. 👉 Enter the contest: https://lnkd.in/e7HBJjGc #WomenInSTEM #WomenInScience

We've all been there... chipping ice off freezer racks and sifting through expired, decades-old reagents. You deserve better than a crumpled printout taped to the fridge. What's the secret to effective sample management? Check out our guide for the top 5 principles: https://lnkd.in/e_Jtqbnj

Only 23% of small #biopharma have adopted #AI. Why is that? While some companies started with an AI-driven strategy, many more would need significant retooling — and they're uncertain about ROI. 👉 See what they’re prioritizing instead. Download the report: https://lnkd.in/evS3D4XS

"It’s insanely simple and disproportionally valuable for scientists’ user experience, productivity, and accuracy," says Benchling user Ken Robbins. What is it? Single input fields for tables, so you can automatically apply the same value down an entire column. "When I first started to use this feature, it wasn’t clear how often I’d use it. By the end of the day (literally), I had updated six templates (it took seconds) that I happened to be working on." 👉 See what else is new: https://lnkd.in/gaaB88gm